TScan Therapeutics
162 employees
Biotech/Pharma
Series C · $180.0M
Open positions (8)
Company details
Team Size162
IndustryBiotech/Pharma
Funding
Total raised
$180.0M
Last stage
Series C
Investors
RA Capital Management
Total raised
$180.0M
Last stage
Series C
Investors
Lea Hachigian
Co-founder of TScan Therapeutics and Longwood Fund Principal. Named in Forbes 2020 30 Under 30 list. Led TScan's strategy to generate novel immunotherapies based on TCR discovery technology.
Tomasz Kula
Co-founder of TScan Therapeutics and Ph.D. scientist. Developed TScan's core TCR discovery technology in the laboratory of Dr. Stephen Elledge at Harvard Medical School. Named in Forbes 2020 30 Under 30 list.
Christoph Westphal
Co-founder and startup CEO of TScan Therapeutics.
No applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.